Evidence map›Paper›PMID 40470145›Full record

ArticleERJ open research2025

Long COVID-19 and longer sick leave: longitudinal study of economically active patients.

Virginia Gallo González, Daniel López-Padilla, Javier de Miguel Díez, Sergio Suárez Escudero, Elena Ojeda Castillejo, Zichen Ji, Luis Puente Maestu

Abstract read
In one paragraph

Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Virginia Gallo GonzálezRespiratory Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Daniel López-PadillaRespiratory Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.ORCID https://orcid.org/0000-0001-8858-1070
Javier de Miguel DíezRespiratory Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.ORCID https://orcid.org/0000-0003-4543-573X
Sergio Suárez EscuderoRespiratory Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Elena Ojeda CastillejoRespiratory Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Zichen JiInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.ORCID https://orcid.org/0000-0002-1086-4131
Luis Puente MaestuRespiratory Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.ORCID https://orcid.org/0000-0001-8501-0117

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Sick leave was one of the numerous consequences of the COVID-19 pandemic. Given the relevance of occupational status for any individual, the aim of the study was to evaluate the impact of persistent symptoms after active infection and determine factors associated with longer sick leaves (LSLs). Methods: This observational study focused on economically active patients attending a post-COVID outpatient clinic for persistence of symptoms or radiological alterations after active infection. The LSL temporal cut-off point was defined by the third tertile of total leave days. Median leave time was compared with the optimal sick leave time for any other viral pneumonia, estimated by the local Ministry of Employment. To determine factors associated with LSL, multivariate models were ultilised. Results: A total of 248 patients were included. The median sick leave time for the entire population was 53 days (interquartile range (IQR) 37.0-126.5), global sum of 30 169 days; the median optimal sick leave time was 21.9 days (IQR 19.7-25.9) (p<0.05). The third tertile cut-off point for LSL was 83 days and multivariate analysis showed a significant association with dyspnoea (OR 3.26, 95% CI 1.59-6.70, p=0.0001), while physical exercise of at least 10 min·day Discussion: COVID-19 sick leave was considerably longer than that stipulated for nonsevere acute respiratory syndrome coronavirus 2 viral pneumonia. Long-COVID syndrome, especially dyspnoea, seems to be a very present factor in these patients' inability to work.

Identifiers

PMID40470145
PMCPMC12134929

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.